Skip to main content

Find Clinical Trials

Home
Conditions
Lymphohistiocytosis, Hemophagocytic

Clinical trial condition

Lymphohistiocytosis, Hemophagocytic

Explore clinical trials studying Lymphohistiocytosis, Hemophagocytic. Study availability and eligibility vary by location and protocol.

65 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Lymphohistiocytosis, Hemophagocytic trial results

Active, Not Recruiting

Immune Disorder HSCT Protocol

NCT01821781

Conditions: 22q11 Deletion Syndrome, Abnormalities, Multiple, Albinism, +66 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Active, Not Recruiting

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

NCT05236764

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Anemia, +39 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

NCT01966367

Conditions: Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndromes, Amegakaryocytic Thrombocytopenia, +65 more
Locations: Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University New York, United States

View Trial Details

Active, Not Recruiting

Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis

NCT06587191

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Non-Langerhans-Cell, +3 more
Locations: Research Institute of Pediatric Hematology, Oncology and Immunology Moscow, Russia

View Trial Details

Active, Not Recruiting

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

NCT02061800

Conditions: Acquired Immunodeficiency Syndrome, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +74 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details